InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Killeen Matthew, Responsable scientifique. Officer active across 1 company, notably Renovacor, Inc.. In total, 2 filings have been published. Activity tracked since 24 January 2022. The latest transaction was disclosed on 24 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Matthew Killeen serves as Chief Scientific Officer of Renovacor, Inc. In this role, he oversees the company's research and development activities, contributing to innovation in the field of gene therapies. Renovacor, Inc. is a biopharmaceutical company specializing in developing treatments for heart diseases. With his expertise, Mr. Killeen plays a key role in advancing research projects.